James Falabella

Staff Scientist at Vaxcyte, Inc - San Carlos, CA, US

James Falabella's Colleagues at Vaxcyte, Inc
Geetanjali Kabra

Associate Director of Accounting

Contact Geetanjali Kabra

Sally Bolmer

S.V.P Regulatory Affairs

Contact Sally Bolmer

Manvi Hasija

Director of Stability

Contact Manvi Hasija

Maggie Sisti

Vice President, Clinical Operations

Contact Maggie Sisti

Katherine Peffen

MSAT Engineer II, Polysaccharide

Contact Katherine Peffen

Nathan Cracraft

Vice President, IT & Facilities

Contact Nathan Cracraft

View All James Falabella's Colleagues
James Falabella's Contact Details
HQ
650-837-0111
Location
San Francisco,California,United States
Company
Vaxcyte, Inc
James Falabella's Company Details
Vaxcyte, Inc logo, Vaxcyte, Inc contact details

Vaxcyte, Inc

San Carlos, CA, US • 100 - 249 Employees
BioTech/Drugs

Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Vaxcyte's lead candidate, VAX-24, is a 24-valent, broad-spectrum pneumococcal conjugate vaccine being developed for the prevention of invasive pneumococcal disease. Vaxcyte is re-engineering the way highly complex immunizations are made through modern synthetic techniques, including advanced chemistry and the XpressCFᵀᴹ cell-free protein synthesis platform, exclusively licensed from Sutro Biopharma, Inc. Unlike conventional cell-based approaches, the Company's system for producing difficult-to-make proteins and antigens is intended to accelerate its ability to efficiently create and deliver high-fidelity vaccines with enhanced immunological benefits. Vaxcyte's pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of greater than 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease. Vaxcyte is driven to eradicate or treat invasive bacterial infections, which have serious and costly health consequences when left unchecked.

B2B Biotechnology Healthcare Pharmaceuticals BioTech/Drugs Commercial Physical Research Biotech Pharmaceuticals
Details about Vaxcyte, Inc
Frequently Asked Questions about James Falabella
James Falabella currently works for Vaxcyte.
James Falabella's role at Vaxcyte is Staff Scientist.
James Falabella's email address is ***@vaxcyte.com. To view James Falabella's full email address, please signup to ConnectPlex.
James Falabella works in the Research industry.
James Falabella's colleagues at Vaxcyte, Inc are Geetanjali Kabra, Sally Bolmer, Manvi Hasija, Maggie Sisti, Katherine Peffen, Nathan Cracraft, Teddy Sinn and others.
James Falabella's phone number is 650-837-0111
See more information about James Falabella